Amulet Capital Partners Closes Continuation Vehicle to Support Continued Growth of US Fertility Led by StepStone

Amulet Capital Partners closed a recapitalization of US Fertility through a new continuation vehicle, with StepStone Group serving as sole lead investor alongside existing and new investors. Financial terms were not disclosed. The transaction extends private-equity backing for a leading U.S. fertility-services platform and signals continued institutional investor interest in healthcare services assets.

Analysis

For STEP, the relevant signal is not a near-term earnings event but incremental evidence that its private-equity solutions platform can deploy capital into continuation vehicles, a fee-bearing AUM category supported by institutional demand for liquidity without forced asset sales. The financial contribution is unknowable without transaction size, fee rate, STEP's ownership share, and whether the commitment sits on balance sheet; therefore, the announcement alone should not alter FY estimates. It is modestly supportive of fundraising credibility and deployment pace over the next 6-18 months, both of which matter more to STEP's multiple than a single deal's economics.

Continuation-vehicle activity is a double-edged indicator for alternative managers. A healthy exit environment would normally reduce the need for these structures, but constrained traditional M&A and IPO exits can expand the supply of GP-led transactions and make STEP a liquidity provider at attractive entry valuations. The risk is adverse selection: sponsors most eager to roll assets may be extending holding periods on businesses whose organic growth has slowed. In healthcare services, reimbursement pressure, labor costs, and fertility-treatment demand cyclicality could impair the underlying asset and create marks below sponsor expectations, weakening returns and future LP appetite.

The non-obvious beneficiary is STEP's broader secondary/solutions franchise rather than direct healthcare exposure: repeated sole-lead mandates can reinforce sourcing advantages and potentially improve future fee-related earnings visibility. Conversely, listed alternative managers with heavier dependence on realization-driven carried interest—BX, KKR, APO—could face a perception gap if private-market liquidity remains dependent on continuation vehicles rather than strategic exits, though this single transaction is far too small to establish that trend. Falsify the constructive STEP view if quarterly disclosures show slowing fee-earning AUM, reduced deployment, wider private-equity valuation markdowns, or management flags lower realization activity.

Key Decisions for Investors

• No standalone event trade in STEP: wait for the next earnings release and initiate/add only if fee-earning AUM and deployment exceed guidance while FRE margins remain intact. The missing transaction economics prevent a defensible estimate revision today.
• Maintain a 6-12 month relative-value watch: long STEP versus short a broad alternative-asset-manager basket only if STEP demonstrates sustained solutions/secondaries fundraising growth and the sector's realization environment remains weak. Thesis target is relative multiple expansion from more durable fee income; stop on two consecutive quarters of AUM/deployment deceleration.
• For existing STEP longs, treat this as a modest qualitative positive rather than a catalyst. Reduce exposure if private-market marks deteriorate materially or if management indicates continuation-vehicle capital is crowding out higher-return secondary opportunities.
• Monitor quarterly disclosures from BX, KKR and APO for realization and carried-interest trends. A widening gap between stable STEP fee-related earnings and weaker realization-dependent income would create a more actionable pair-trade entry over the next 1-3 months.